Panel predicts whether rare leukemia will respond to treatment

Patients with chronic myelomonocytic leukemia have limited treatment options, and those that exist are effective only in fewer than half of patients. Now, a new study identifies a panel of genetic markers that predicted which tumor samples would likely respond to treatment.



from Latest Science News -- ScienceDaily http://ift.tt/19t9wV8 via Karis World